| 摘要 |
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases. |
| 申请人 |
AMIRA PHARMACEUTICALS, INC. |
发明人 |
ROPPE, JEFFREY ROGER;LI, YIWEI;ZUNIC, JASMINE ELEANOR;STEARNS, BRIAN ANDREW;STOCK, NICHOLAS SIMON;ARRUDA, JEANNIE M.;MORAN, MARK;EVANS, JILLIAN F.;HADDACH, MUSTAPHA;HUTCHINSON, JOHN H.;PRASIT, PETPIBOON PEPPI |
